Hepatitis B Clinical Trials
Hepatitis B clinical trials test new treatments, vaccines, and prevention strategies for hepatitis B. Corterve compiles actively recruiting Hepatitis B studies from the ClinicalTrials.gov registry so you can filter by where you live and whether you may qualify. This page is educational and not medical advice; consult a qualified clinician about participating.
Recruiting Hepatitis B studies
- Evaluation of Patients With Liver DiseaseNCT00001971National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Bethesda, Maryland
- VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis BNCT06092333PHASE2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Bethesda, Maryland
- Blood Collection Biorepository for Liver Disease ResearchNCT03025074State University of New York at BuffaloBuffalo, New York
- Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesNCT05832229PHASE2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)La Jolla, California
- Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in CirrhosisNCT04588077PHASE4Mercy Medical CenterBaltimore, Maryland
- Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal FunctionNCT07342881PHASE1Aligos TherapeuticsOrlando, Florida
- National Liver Cancer Screening TrialNCT06084234PHASE4University of Texas Southwestern Medical CenterLos Angeles, California
- Adaptability of an Undetectable = Untransmissible Model for HBVNCT07449091NYU Langone HealthNew York, New York
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus InfectionNCT07024641PHASE1GigaGen, Inc.Chandler, Arizona
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.NCT00404989Syneos HealthWilmington, North Carolina
- A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)NCT06963710PHASE2Aligos TherapeuticsChandler, Arizona
- HepB mAb19 in Individuals With Chronic Hepatitis B InfectionNCT05856890PHASE1Rockefeller UniversityNew York, New York
Hepatitis B trials by state
Hepatitis B trials by metro
Frequently asked questions
- How do I find recruiting Hepatitis B clinical trials?
- Corterve aggregates actively recruiting Hepatitis B studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Hepatitis B clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Hepatitis B clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.